Navigation Links
U of T research finds glycine could be key to REM Sleep Behavior Disorder
Date:3/27/2008

TORONTO, ON. There is new promise on the horizon for those who suffer from REM Sleep Behaviour Disorder (RBD) according to researchers at the University of Toronto.

RDB, a neurological disorder that causes violent twitches and muscle contractions during rapid eye-movement (REM) sleep, can lead to serious injuries. John Peever, Assistant Professor at the University of Toronto, discovered that an inhibitory brain chemical called glycine is responsible for actively suppressing muscle twitches in REM sleep. Deficiency in glycine levels in the brain cells that control muscles (motoneurons) was found to cause the violent muscle contractions that mimic the primary symptom of RBD.

This study shows the mechanism that suppresses muscles twitches in REM sleep and this will lead to better treatments and potential cures for this disorder, says Peever. Treating REM sleep disorder may have much broader implications, since within five to eight years of being diagnosed with this disorder, 60-80% of individuals eventually develop Parkinsons disease.


'/>"/>

Contact: Christa Poole
christa.poole@utoronto.ca
University of Toronto
Source:Eurekalert

Page: 1

Related medicine news :

1. UC Irvine researchers present latest findings at emergency medicine forum
2. Target Data Research Sponsors Forgotten Citizens Who Are in Need of Public Guardianship To Support and Manage Their Healthcare and Personal Needs
3. Researchers urge ethics guidelines for human-genome research
4. Hiemstra Appoints Daniel C. Rosenman as Vice President of Research & Development
5. MarketResearch.com Announces Distribution of Wireless Healthcare Research
6. MarketResearch.com Announces Distribution of CarbonFree Research
7. OHSU Cancer Institute researchers identify new approach to help control drug resistance in leukemia
8. FSU researchers mutant proteins could lead to new treatment for heart disease
9. Source Endurance and So High Sports Announce Research Alliance for Physiology and Human Performance
10. Research Shows Patients With Psoriasis at Increased Risk for Developing Other Serious Medical Conditions
11. NYU dental researchers find evidence of periodontal disease leading to gestational diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2008)...ans Health Care, WASHINGTON, July 9 /PRNewswire-U...f Government Employees (AFGE) launched a nationwid... Senator McCain,s commitment to,veterans, health c...resents,employees in the Department of Veterans Af...com, and a series of YouTube ads featuring union ...
(Date:7/9/2008)...promazine Maleate (Acepromazine) is on extended ba...will compound this preparation into Gourmeds™...vored suspension in the most frequently prescribed...cription for veterinary use only. , ...uly 9, 2008 -- Commonly prescribed for both cats ...
(Date:7/9/2008)...enses to Protect Eyes This Summer and ...Fla., July 9 /PRNewswire/ -- While consumers are a...ts effects on the skin, many,are not aware that th...by,the New England Eye Institute and Transitions O...eport knowing that UV exposure can cause skin canc...
(Date:7/9/2008)...USNewswire/ -- Updates on the impact of,climate ch...A infections,and the importance of childhood immu...e at the National Press Club in Washington, D.C. T...dation for Infectious Diseases,(NFID), also addres...ent of,infections due to drug resistant bacteria.,...
Breaking Medicine News(10 mins):Health News:Union Representing VA Workers Launch Nationwide Radio Campaign, Web Site and Viral Videos for Full VA Funding 2Health News: Wedgewood Pharmacy Responds to Acepromazine Maleate Drug Shortage 2Health News:Study Confirms Americans Place Their Vision at Risk Year Round 2Health News:Study Confirms Americans Place Their Vision at Risk Year Round 3Health News:Public Health Experts Provide Update on Current Infectious Diseases Threats 2Health News:Public Health Experts Provide Update on Current Infectious Diseases Threats 3
Detect masses in the breast
... injury to most or all of both lungs. Patients wit...re on life support. //A new study finds the age of...fter a trauma. ARDS is not a specific disease; ins... associated with a number of diseases including pn...
...of viral particles isolated from humans with SARS ...ed //and being held in a retail food market. The a...99.8 percent genetically identical to a virus that...y syndrome, or SARS, in humans. Their findings sug...
...rmone could suppress the appetites of lean people.... obese people because studies of another appetite-...nting. "We had to do a second trial to see if obes...ne, said researchers. The answer: "Yes, they are. ...
Other Medicine News:Health News:SARS research confirms link to animals 2Health News:Extra hormone found to cut appetite by a third 2
(Date:7/7/2008)...swire-FirstCall/ -- GeoVax Labs, Inc. (OTC,Bulleti...biopharmaceutical,company specializing in the prev... provided an operational update on the company,s p...n clinical trial testing and,plans to proceed into...ive,successful human trials evaluating GeoVax AIDS...
(Date:7/7/2008)...s Kiwifruit is Top Performer in the Body, SEATTLE...d equal when,it comes to their antioxidant powers ...availability compared to other antioxidant-rich fr...lished in the Journal of the,American College of N...ochemicals called flavonoids that,may have the pow...
(Date:7/3/2008)... /PRNewswire-USNewswire/ -- All newborn infants,sh...is present at birth,according to a new recommenda... The recommendation and the accompanying summary o...s., Children whose hearing is impaired at birth, ...lems with verbal and nonverbal communication and,s...
(Date:7/2/2008)...ficacy Endpoint Met in Stage 1 of Two-Stage Study ...valuable Patients to Date Continue to Show Objecti...isease -, TUSTIN, Calif., July 2 /PRNewswire-Firs... PPHM ) today reported that its lead product,cand... 1 primary endpoint,in its ongoing Phase II clinic...
Breaking Medicine Technology:GeoVax Reports Progress on Its AIDS Vaccine Technology 2GeoVax Reports Progress on Its AIDS Vaccine Technology 3GeoVax Reports Progress on Its AIDS Vaccine Technology 4GeoVax Reports Progress on Its AIDS Vaccine Technology 5Kiwifruit: Antioxidant Power in Quantity and Quality 2Task Force Recommends Screening for Hearing Loss in All Newborns 2Task Force Recommends Screening for Hearing Loss in All Newborns 3Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer 2Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer 3Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer 4iPlant Kickoff Conference at CSHL begins tackling plant biologys grand challenges 2763 1iPlant Kickoff Conference at CSHL begins tackling plant biologys grand challenges 2763 2iPlant Kickoff Conference at CSHL begins tackling plant biologys grand challenges 2763 3Parker Extends Precise Medical Seal Capability 3B Acquires Hi Tech Group Companies 16021 1Parker Extends Precise Medical Seal Capability 3B Acquires Hi Tech Group Companies 16021 2Parker Extends Precise Medical Seal Capability 3B Acquires Hi Tech Group Companies 16021 3QED International Associates Announces Changes to the HealthShares 28TM 29 Cardio Devices Index 28As Revised 29 16018 1Medicare Bidding Program in Kansas City is Plagued by Problems Says American Association for Homecare 16014 1Medicare Bidding Program in Kansas City is Plagued by Problems Says American Association for Homecare 16014 2Medicare Bidding Program in Kansas City is Plagued by Problems Says American Association for Homecare 16014 3
...il 21, 2007-Genentech and FDA notified,healthcare ...regarding tracheoesophageal (TE) fistula formation...ed-stage small cell lung,cancer (SCLC). This multi...al trial study combined chemotherapy and radiation...us adverse events of TE,fistula (one fatal) report...
...16, 2007 /PRNewswire/ -- Sirion Therapeutics,Inc.... announced,today that it has received orphan drug ...(FDA) for its anti-viral therapy,ganciclovir, for...oduct is currently marketed by Laboratoires Thea i... licensed the rights to,Virgan(R) for the United S...
Other Medicine Technology:Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic,Drug to Treat Viral Eye Infection 2
The Reusable Template is designed for use with the Brachystepper® as a guidance system for prostate brachytherapy. Please be sure that the graphics on your software match the graphics on the Reus
The MicroTouch LP (low profile) is specifically designed for use on cystoscopy tables with a fixed fluoroscopy/x-ray gantry. The MicroTouch LP attaches to tables on the side opposite the gantry and a
The Precision Stepper is the first stepper with a fully adjustable baseline. This new technology permits the physician to fine-tune the depth of the ultrasound transducer for accurate imaging and pr
The specially designed table-mounted stepper/stabilizer offers the strength and stability necessary for a flawless delivery of brachytherapy.
Medicine Products: